Skip to content

Clinical trials

Completed Liver Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Status: Completed Country / region: South Korea Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20065
20084
20092
20101
20113
20121
20133
20143
20153
20164
20174
20192
20202
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital6
Jennerex Biotherapeutics5
Bayer4
Bristol-Myers Squibb4
Asan Medical Center3
Novartis Pharmaceuticals3
Imunon2
Pfizer2
Arbutus Biopharma Corporation1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms45
Carcinoma, Hepatocellular28
Neoplasms4
Vaccinia3
Biliary Tract Neoplasms2
Liver Diseases2
Neoplasm Metastasis2
Pancreatic Neoplasms2
Adenocarcinoma1
Bile Duct Neoplasms1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.